-PainCare-

###########
■ Review of 2020 and Engagement of Patient Organisations ■

The International Painful Bladder Foundation has published an updated overview of the project. See this review here.

Read More…

###########
■ Managing pain ■

Recent news from subproject TRiPP:
We recently worked with Health Awareness on the 2020 Managing Pain campaign. A printed publication was enclosed within every copy of the New Scientist magazine and the content is available online at https://bit.ly/34sqgfq The campaign featured exclusive content from key thought leaders and industry about living with chronic pain on a daily basis and the challenges of diagnosing and treating the pain associated with conditions such as Endometriosis and Interstitial Cystitis/Bladder Pain Syndrome.

###########
■ IMI-PainCare meets EQIPD ■

The need of quality standards in preclinical research is a topic gaining attention in the last years, especially in translational research. The IMI-PainCare consortium have reached out another IMI initiative: European Quality in Preclinical Data (EQIPD; https://quality-preclinical-data.eu/) to collaborate in assessing the study design and data analysis for our studies within subgroups BioPain and TRiPP. This collaboration will ensure equivalent quality standards in preclinical research among the project members, allowing for a successful reproducibility, reducing failure rates and the time and costs associated. IMI-Pain Care welcomes EQIPD to the team and looks forward to the outputs of this collaboration.

###########
■ INTEGRATE-PAIN, a transatlantic US-European interaction in pain research between the NIH HEAL InitiativeSM and the IMI-PainCare consortium ■

Innovations in pain management are needed to reduce the suffering of many people who cannot be treated adequately with current therapies. As lack of effective and safe pain management is a societal problem, it is in the interests of all stakeholders to interact closely to improve the situation. The NIH HEAL and IMI-PainCare teams realized the congruency of their approaches, which strongly supports that valuable synergies will arise from a transatlantic consensus. Dedicated to improving the understanding, management, and treatment of pain, both teams have prioritized common opportunities in preclinical and clinical research, ultimately accelerating the discovery and development of new non-addictive treatments and improving the management of pain.

Together, we established INTEGRATE-Pain, the “IMI-NIH Transatlantic Emphasis Group on Research And Translation-to-care Efforts for Pain”. Our objectives are transatlantic knowledge sharing, harmonizing of standards, combination of infrastructures, coordination of data collection to improve the statistical power of data interpretation in future meta-analyses, and joint dissemination.

On August 5th and 6th 2020, INTEGRATE-Pain will have virtual meetings, originally planned as personal appointments during the IASP 2020 World Pain Congress.

The NIH HEAL Initiative:
The Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM, is an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis. Almost every NIH Institute and Center is accelerating research to address this public health emergency from all angles.

The initiative is funding hundreds of projects nationwide. Researchers are taking a variety of approaches to tackle the opioid epidemic through:
  • Understanding, managing, and treating pain
  • Improving treatment for opioid misuse and addiction
More information on the NIH HEAL Initiative: https://heal.nih.gov/.

###########
■ Project status on SIP platform ■

Project lead Petra Bloms-Funke published a short overview about the status of IMI-PainCare entitled "WHAT HAS HAPPENED SINCE IMI PAIN CARE WAS LAUNCHED?"

Screen Shot 2019-07-29 at 11.07.32


Read More…